News

Extract Technology Ltd and CPi Technology Announce Ireland Agency Agreement

Extract Technology Limited has made an exclusive distribution agreement with CPi Technology for Ireland. The newly established partnership will provide a greater level of service and local support to customers in Ireland. Extract Technology based in Huddersfield UK & New Lisbon USA are market leaders specializing in the supply of high quality containment and aseptic equipment for the pharmaceutical and biotechnology sectors. Extract Technology manufactures, fully assembles and tests the equipment in-house. The company has global coverage with manufacturing capabilities…

Refine Technology, LLC Establishes East Coast Distribution for New 1.5″ Single Use Connector

Today, Refine Technology, most known for developing the award winning ATF™ System for cell perfusion, announced distribution arrangements with three companies to help promote and sell its new CleanLine™ 1.5” Single Use Connector on the east coast. Refine Technology has partnered with Triangle Process Equipment in Wilson, NC, Accuflow Systems in Frederick, MD and Casella Process Systems in Barrington, NH to help develop the market for improved high volume, low shear sterile fluid flow rates in single use bioprocessing. “We…

CEVEC Licenses CAP®Go Technology in the Field of Veterinary Vaccines

CEVEC Pharmaceuticals GmbH (CEVEC), the expert in the production of tailor-made recombinant glycoproteins and gene therapy vectors, today announced that it has signed a non-exclusive license agreement with a leading European veterinary pharmaceutical company for use of its proprietary CAP®Go cells in the development, production and commercialization of two difficult to express recombinant proteins in the field of veterinary vaccines. Under the terms of the agreement, CEVEC provides its expertise in cell line development and in the expression of difficult-to-produce…

GE Healthcare Partners with Oritain to Introduce Independent Test to Confirm Country of Origin of Fetal Bovine Serum

GE Healthcare and Oritain are today launching an independent test-based traceability program to authenticate the country of origin of Fetal Bovine Serum (FBS). FBS is a cell growth supplement used in the manufacturing of biopharmaceuticals and vaccines for human health and veterinary purposes, as well as in basic research and drug discovery. Serum plays an important role in the cell-based production of high-quality vaccines and therapeutics for people and animals around the world. Morgan Norris, General Manager for Upstream and…

Quattroflow™ Launches EZ-Set Pump Chamber Replacing System for Single-Use Pumps

Quattroflow™, part of PSG®, a Dover company and a leading brand of positive displacement quaternary diaphragm pumps, is pleased to announce the launch of the EZ-Set Pump Chamber Replacing System for its Single-Use pumps. With EZ-Set, users can replace a Single-Use pump chamber in 30 seconds by hand without the use of special tools or torque wrenches. It’s quick, it’s easy, and it’s safe. The comfortable handgrip design of the EZ-Set makes replacing the pump chamber so easy you can…

Selexis Announces Commercial License Agreement with Takeda for the Development of Fusion Proteins

Selexis SA, a pioneering life sciences company and a global leader in mammalian cell line generation technology, announced today that it has entered a commercial license agreement (CLA) that provides Takeda Pharmaceutical Company Limited [TSE:4502], (“Takeda”) with access to high-performance research cell banks (RCBs) developed using the Selexis SUREtechnology Platform™. Takeda is leveraging Selexis’ mammalian cell line-based protein expression platform to develop recombinant fusion proteins. “Successfully developing a high-performance cell line expressing Takeda’s fusion proteins validates the strength of our…

Sartorius Stedim Biotech introduces Sartobind® Cassettes

Sartorius Stedim Biotech (SSB), a leading international supplier for the biopharmaceutical industry, has expanded its range of single-use membrane chromatography solutions with Sartobind® Cassettes. This convenient, pod-like modular system has been developed for commercial applications in both capture and polishing. New Sartobind® cassettes offer the same flow path, bed heights (4 and 8 mm) and void volume ratios as Sartobind® capsules, and are compatible with Q, S, STIC PA and phenyl ligands. The new design goes beyond the previous 5…

KBI Biopharma Acquires Alliance Protein Laboratories, Expands Biophysical Characterization Capabilities

KBI Biopharma, Inc. (KBI) has agreed to acquire the assets of San Diego-based Alliance Protein Laboratories (Alliance), a leading analytical services company specializing in biophysical characterization of biopharmaceuticals. Founded in 1998, Alliance is well known and highly regarded around the world for its expertise in characterization of therapeutic proteins, peptides, nucleic acids and vaccines. Recognized as the foremost expert in analytical ultracentrifugation (AUC), an essential technology for determining physical stability, association state, molecular weight and quantitative characterization of protein aggregates,…

JSR Life Sciences Acquires Cell Line Developer Selexis SA, Integrates With KBI Biopharma, Inc.

JSR Life Sciences (JLS) announced today that JSR Corporation has agreed to acquire Selexis SA, a pioneering life sciences company and global leader in mammalian (suspension-adapted CHO-K1) cell-line generation technologies. Once completed, this transaction will mark the second major biotechnology addition to the JSR group of companies following JSR Corporation’s acquisition of KBI Biopharma in 2015. Selexis will be integrated within KBI Biopharma’s operations to create the most robust and fastest “Gene to GMP” service offering in the biopharmaceutical industry.…

Rentschler Biotechnologie and Rentschler Fill Solutions Announce Strategic Partnership for One-Stop Solutions with New State-of-the-Art Fill and Finish Facilities

Rentschler Biotechnologie GmbH, a leading contract development and manufacturing organization (CDMO) for biopharmaceuticals, and Rentschler Fill Solutions GmbH, an independent specialist for aseptic fill and finish services, today announced a strategic partnership to provide new state-of-the-art fill and finish facilities and one-stop solutions for biopharmaceutical products to meet the needs of Rentschler Biotechnologie’s clients. Under the terms of the agreement, Rentschler Fill Solutions will prospectively serve as the exclusive partner for the fill and finish services of Rentschler Biotechnologie’s manufacturing…